Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Advisors And Industry Groups Press Agency To Delay Outpatient System Changes

This article was originally published in The Gray Sheet

Executive Summary

CMS faces pressure from one of its advisory panels and the device industry to delay implementation of proposals in its draft 2014 hospital outpatient payment rule related to the development of comprehensive ambulatory payment classifications, implementation of new cost centers for CT and MRI, and seven new packaging policies.

You may also be interested in...



Imaging Industry Spared 30 Percent Cuts, But Anxiety Remains

CT and MRI scans won’t be subject to the 20 to 30 percent cuts in reimbursement that industry had feared thanks to a policy shift from CMS’ initial proposal in the Medicare hospital outpatient prospective payment system final rule.

Packaging Policies Finalized, Comprehensive Payments Delayed In Medicare Outpatient Pay Reg

In its final 2014 hospital outpatient prospective payment system rule, CMS finalized proposals in the draft regulation to package payment rates for certain categories of device-dependent items and services, and to create 29 comprehensive ambulatory payment classifications to replace existing ones.

New AdvaMed Exec Donald May Weighs In On Reimbursement Priorities

In an interview with “The Gray Sheet,” Donald May, the new executive vice president of payment and health care delivery policy at AdvaMed, discusses priorities in his new role with the association.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel